Global X Emerging Markets Eq Index Corp Class ETF Vs. Collegium Pharmaceutical Industry Stock Comparison

Buy

58

HXEM.TO
Global X Emerging Markets Eq Index Corp Class ETF

Last Price:

$37.41

Seasonality Move:

0.79%

Sell

45

COLL
Collegium Pharmaceutical

Last Price:

$33.33

Seasonality Move:

-1.63%

Buy

58

Global X Emerging Markets Eq Index Corp Class ETF (HXEM.TO) is a Buy

Is Global X Emerging Markets Eq Index Corp Class ETF a Buy, Sell or Hold?

The current Global X Emerging Markets Eq Index Corp Class ETF [HXEM.TO] share price is $37.41. The Score for HXEM.TO is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
HXEM.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

45

Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HXEM.TO Stock Price Chart

What is Global X Emerging Markets Eq Index Corp Class ETF's stock price today?

The Global X Emerging Markets Eq Index Corp Class ETF share price today is $37.41

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HXEM.TO is experiencing slight selling pressure.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

The Collegium Pharmaceutical share price today is $33.34

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

HXEM.TO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.08	Sell
Relative Strength Index (14 RSI):	42.12	Sell
Chaikin Money Flow:	-431	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(37.46 - 38.36)	Sell
Bollinger Bands (100):	(36.47 - 38.67)	Sell

COLL Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.27	Sell
Relative Strength Index (14 RSI):	66.05	Buy
Chaikin Money Flow:	1007158	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(28.9 - 30.94)	Buy
Bollinger Bands (100):	(30.52 - 37.92)	Sell

HXEM.TO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	37.73	Sell
20-day SMA:	38.04	Sell
50-day SMA:	37.88	Sell
200-day SMA:	36.55	Buy
8-day EMA:	37.69	Sell
20-day EMA:	37.83	Sell
50-day EMA:	37.82	Sell
200-day EMA:	36.5	Buy

COLL Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	29.45	Buy
20-day SMA:	29.79	Buy
50-day SMA:	30.91	Buy
200-day SMA:	34.47	Sell
8-day EMA:	30.02	Buy
20-day EMA:	29.94	Buy
50-day EMA:	31.21	Buy
200-day EMA:	32.94	Buy

Global X Emerging Markets Eq Index Corp Class ETF Earnings Growth & HXEM.TO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

Global X Emerging Markets Eq Index Corp Class ETF Technical Analysis

	Dec 19	Dec 20	Dec 24	Dec 27	Dec 30	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	19	20	24	27	30	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Collegium Pharmaceutical Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):